Greenphage creates bacteriophage solutions for human, animal, and plant health to combat bacterial infections.
Greenphage has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Greenphage's investors include IRDI SORIDEC Gestion, Sofilaro, Environnement Massif Central, Sud Mer Invest.
Greenphage is headquartered in Clapiers, France.
Greenphage creates bacteriophage solutions for human, animal, and plant health to combat bacterial infections.
Greenphage is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Greenphage — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/greenphage. Accessed September 15, 2026.
VCBacked. (2025). Greenphage — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/greenphage
{{cite web |title=Greenphage — Funding & Investors |url=https://www.vcbacked.co/company/greenphage |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated